- Home
- SCPH
as 09-16-2025 4:00pm EST
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.
| Founded: | 2013 | Country: | United States |
| Employees: | N/A | City: | BURLINGTON |
| Market Cap: | 299.0M | IPO Year: | 2017 |
| Target Price: | $12.00 | AVG Volume (30 days): | 2.4M |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.77 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.94 - $6.28 | Next Earning Date: | 11-12-2025 |
| Revenue: | $49,969,000 | Revenue Growth: | 107.79% |
| Revenue Growth (this year): | 108.95% | Revenue Growth (next year): | 78.30% |
Latest scPharmaceuticals Inc. News
SCPH Breaking Stock News: Dive into SCPH Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 months ago
With 42% stake, scPharmaceuticals Inc. (NASDAQ:SCPH) seems to have captured institutional investors' interest
Simply Wall St.
4 months ago
scPharmaceuticals First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Thomson Reuters StreetEvents
4 months ago
Q1 2025 scPharmaceuticals Inc Earnings Call
GuruFocus.com
4 months ago
scPharmaceuticals Inc (SCPH) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Expansion
Zacks
4 months ago
ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates
GlobeNewswire
4 months ago
scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
GuruFocus.com
4 months ago
scPharmaceuticals Inc (SCPH) Q1 2025: Everything You Need To Know Ahead Of Earnings
GlobeNewswire
4 months ago
scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025
Compare SCPH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SCPH scPharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.